Human ST2/IL-33R LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™

Llama Monoclonal Antibody

Supplier:  R&D Systems LMAB108591SP

Catalog No. LMAB108591S

Description

ST2/IL-33R Monoclonal antibody specifically detects ST2/IL-33R in Human samples. It is validated for Immunocytochemistry

Specifications

• Antigen: ST2/IL-33R
• Classification: Monoclonal
• Conjugate: Unconjugated
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
• Gene Alias: DER4, DER4ST2growth stimulation-expressed, FIT-1, IL-1 R4, IL1R4, IL-1R4, IL-1RL1, IL-33 R, IL33R, IL-33R, interleukin 1 receptor-like 1, interleukin 1 receptor-related protein, interleukin-1 receptor-like 1, Ly84, MGC32623, Protein ST2, ST2L, ST2V, T1, T1homolog of mouse growth stimulation-expressed
• Immunogen: Mouse myeloma cell line NS0-derived human ST2/IL-33R as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody, Lys19-Phe328, Accession # BAA02233
• Quantity: 25 μg
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.

• Applications: Immunocytochemistry
• Clone: L000.2.694H
• Dilution: Immunocytochemistry 8-25 ug/mL
• Gene Accession No.: BAA02233
• Host Species: Llama
• Purification Method: Protein A or G purified from cell culture supernatant
• Regulatory Status: RUO
• Gene ID (Entrez): 9173
• Target Species: Human
• Form: Purified